Professor of Oncology, Johns Hopkins University School of Medicine; Visiting Professor
Oncology
Dr. Lode J. Swinnen, MD
|
|
Give Review
Lode J. Swinnen works in the field of Oncology. He over the years received 1 awards: "CMS Meaningful Use Stage 1 Certification". Doctor Lode J. Swinnen, MD is a published physician. He has 76 papers published. The most current publication "Geographically distinct HHV-8 DNA sequences in Saudi Arabian Iatrogenic Kaposi's sarcoma lesions." He accepts all Medicare patients.
Publications
- Central Nervous System Cancers, Version 1.2015.
- Risk-stratified outcomes of nonmyeloablative, HLA-haploidentical BMT with high-dose posttransplantation cyclophosphamide.
- Central nervous system Cancers, version 2.2014.
- Post-transplantation cyclophosphamide as single-agent GVHD prophylaxis after myeloablative conditioning and HLA-matched allografting for Acute leukemias and myelodyspl...
- Bevacizumab and cyclosphosphamide, doxorubicin, vincristine and prednisone in combination for patients with peripheral T-Cell or natural killer Cell neoplasms: an East...
- Absence of Post-Transplantation Lymphoproliferative Disorder after Allogeneic Blood or Marrow Transplantation Using Post-Transplantation Cyclophosphamide as Graft-vers...
- Non-Hodgkin's Lymphomas, Version 1.2013.
- Brief intensive therapy for older adults with newly diagnosed Burkitt or atypical Burkitt lymphoma/Leukemia.
- Outcomes of Related Donor HLA-Identical or HLA-Haploidentical Allogeneic Blood or Marrow Transplantation for Peripheral T Cell Lymphoma.
- Human leukocyte antigen-haploidentical hematopoietic stem Cell transplant for a patient with histiocytic sarcoma.
- Importance of immunoglobulin heavy chain variable region mutational status in del(13q) chronic lymphocytic Leukemia.
- NCCN Clinical Practice Guidelines in Oncology: non-Hodgkin's Lymphomas.
- High-dose chemotherapy with stem Cell rescue as initial therapy for anaplastic oligodendroglioma: long-term follow-up.
- High-dose chemotherapy with stem Cell rescue as initial therapy for anaplastic oligodendroglioma.
- The neurobeachin gene is disrupted by a translocation in a patient with idiopathic autism.
- Randomized trial of a slow-release versus a standard formulation of cytarabine for the intrathecal treatment of Lymphomatous meningitis.
- Characterization of postcardiac transplant Lymphomas. Histology, immunophenotyping, immunohistochemistry, and gene rearrangement.
- Mucosa-associated lymphoid tissue-type Lymphomas occurring in post-transplantation patients.
- A variant of palmaris longus.
- Myeloablative chemotherapy for recurrent aggressive oligodendroglioma.
- Intrathecal treatment of neoplastic meningitis due to breast Cancer with a slow-release formulation of cytarabine.
- Conservation of Epstein-Barr virus cytotoxic T-cell epitopes in posttransplant Lymphomas: implications for immune therapy.
- Post-transplant lymphoproliferative disorder subtypes correlate with different recurring chromosomal abnormalities.
- Epstein-Barr viral load as a marker of Lymphoma in AIDS patients.
- Treatment advances in adult Burkitt lymphoma and Leukemia.
- Epstein-Barr Virus (EBV) DNA in plasma is not encapsidated in patients with EBV-related malignancies.
- FDG PET and high-dose therapy for aggressive Lymphomas: toward a risk-adapted strategy.
- Association of the type of induction immunosuppression with posttransplant lymphoproliferative disorder, Graft survival, and patient survival after primary kidney tran...
- Tumor origin and CD20 expression in posttransplant lymphoproliferative disorder occurring in solid organ transplant recipients: implications for immune-based therapy.
- An open label trial of sustained-release cytarabine (DepoCyt) for the intrathecal treatment of solid tumor neoplastic meningitis.
- Prospective study of sequential reduction in immunosuppression, interferon alpha-2B, and chemotherapy for posttransplantation lymphoproliferative disorder.
- A phase II study of cisplatin preceded by a 12-h continuous infusion of concurrent hydroxyurea and cytosine arabinoside (Ara-C) for adult patients with malignant gliom...
- Induction of autologous graft-versus-host disease: results of a randomized prospective clinical trial in patients with poor risk Lymphoma.
- Association of human leukocyte antigen haplotypes with posttransplant lymphoproliferative Disease after solid organ transplantation.
- Immune-cell treatment of Epstein--Barr-virus-associated lymphoproliferative Disorders.
- Early treatment intensification for aggressive non-Hodgkin's Lymphoma.
- Nonmyeloablative HLA-haploidentical bone marrow transplantation with high-dose posttransplantation cyclophosphamide: effect of HLA disparity on outcome.
- Interim positron emission tomography scans in diffuse large B-cell Lymphoma: an independent expert nuclear medicine evaluation of the Eastern Cooperative Oncology Grou...
- Primary central Nervous system lymphoma: recent progress, many remaining questions.
- Phase II study of risk-adapted therapy of newly diagnosed, aggressive non-Hodgkin Lymphoma based on midtreatment FDG-PET scanning.
- Non-Hodgkin's Lymphomas.
- High-dose cyclophosphamide and rituximab without stem cell transplant: a feasibility study for low grade B-cell, transformed and mantle cell Lymphomas.
- Donor-transmitted malignancies in organ transplantation: assessment of clinical risk.
- Salvage transplantation for alloGraft failure using fludarabine and alemtuzumab as conditioning regimen.
- Organ transplant-related Lymphoma.
- Analytic validation of a competitive polymerase chain reaction assay for measuring Epstein-Barr viral load.
- Frequent expression of the tumor necrosis factor receptor-associated factor 1 in latent membrane protein 1-positive posttransplant lymphoproliferative Disease and HIV-...
- Comparative analysis of the expression of the Epstein-Barr virus (EBV) anti-apoptotic gene BHRF1 in nasopharyngeal carcinoma and EBV-related lymphoid Diseases.
- Post-transplant lymphoproliferative Disorders: implications for acquired immunodeficiency syndrome-associated malignancies.
- Transplantation-related lymphoproliferative disorder: a model for human immunodeficiency virus-related Lymphomas.
- Lung transplantation for advanced bronchioloalveolar carcinoma confined to the Lungs.
- Diagnosis and treatment of transplant-related Lymphoma.
- Simian virus 40 is present in most United States human mesotheliomas, but it is rarely present in non-Hodgkin's Lymphoma.
- A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from soli...
- Overview of posttransplant B-cell lymphoproliferative Disorders.
- Transplant immunosuppression-related malignant Lymphomas.
- Flow and image cytometric DNA analysis of postcardiac transplant Lymphomas.
- OKT3 monoclonal antibodies induce interleukin-6 and interleukin-10: a possible cause of lymphoproliferative Disorders associated with transplantation.
- Methylation status of the Epstein-Barr virus major latent promoter C in iatrogenic B cell lymphoproliferative Disease. Application of PCR-based analysis.
- Geographically distinct HHV-8 DNA sequences in Saudi Arabian Iatrogenic Kaposi's sarcoma lesions.
- Epstein-Barr virus (EBV) variant with a 30-bp deletion at the carboxyl terminus (amino acids 346-355) of latent membrane protein-1 (LMP1) gene is able to transform cel...
- Durable remission after aggressive chemotherapy for post-cardiac transplant lymphoproliferation.
- Treatment of organ transplant-related Lymphoma.
- CpG methylation of the major Epstein-Barr virus latency promoter in Burkitt's Lymphoma and Hodgkin's disease.
- BCL-2 but not its Epstein-Barr virus-encoded homologue, BHRF1, is commonly expressed in posttransplantation lymphoproliferative Disorders.
- O6-methylguanine-DNA methyltransferase in tumors and Cells of the oligodendrocyte lineage.
- Aggressive treatment for postcardiac transplant lymphoproliferation.
- 1-beta-D-arabinofuranosylcytosine and hydroxyurea production of cytotoxic synergy with cis-diamminedichloroplatinum(II) and modification of platinum-induced DNA inters...
- Ultraviolet irradiation produces cytotoxic synergy and increased DNA interstrand crosslinking with cis- and trans-diamminedichloroplatinum(II).
- Cisplatin preceded by concurrent cytarabine and hydroxyurea: a pilot study based on an in vitro model.
- Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients.
- A phase II trial of recombinant tumor necrosis factor in patients with metastatic colorectal adenoCarcinoma: a Southwest Oncology Group study.
- Inhibition of cis-diammine-1,1-cyclobutane dicarboxylatoplatinum(II)-induced DNA interstand cross-link removal and potentiation of cis-diammine-1,1-cyclobutane dicarbo...
- Cytotoxic synergy of cisplatin with concurrent hydroxyurea and cytarabine: summary of an in vitro model and initial clinical pilot experience.
- Cytomegalovirus infections in heart transplant recipients: relationship to immunosuppression.
Schools
University Of Cape Town Faculty Of Health Sciences
Wellington Hospital New Zealan
St Joseph Hospital
Loyola University Hines Va
Procedures Preformed
- Bone Marrow Transplant
- HPC Transplantation (Stem Cell Transplant)
Conditions Treated
- Acute Leukemia
- Anemia
- Bladder Cancer
- Brain and Nervous System Cancer (incl. Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
- Aetna
- Amerigroup (Wellpoint)
- Blue Card PPO
- Blue Preferred PPO
- Great West Healthcare-Cigna PPO
- Commercial Insurance Company
- CoreSource
- Southern Health PPO
- Coventry Health Care of Delaware PPO
- Emblem Health
- First Health (Coventry Health Care) PPO
- Geisinger Health Plan
- Choice Care PPO
- Kaiser Permanente
- MedHealthInsurance
- Medicaid
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Tricare
- Choice Plus POS
- Navigate HMO
- Options PPO
- United Healthcare
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Loyola University -
St Joseph Hospital -
University of Cape Town Faculty of Medicine
Hospital
-
Johns Hopkins Hospital
Drug Facts
| NPI NUMBER | 1417988148 | |
| NPPES Provider LastName | SWINNEN | |
| NPPES Provider FirstName | LODE | |
| NPPES Provider ZIPCode | 212870005 | |
| NPPES Provider State | MD | |
| Specialty Description | Internal Medicine | |
| Total Claim Count | 22.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1417988148 |
| Last Name Of The Provider | SWINNEN |
| First Name Of The Provider | LODE |
| View All |
Similar Doctors
|
|
Dr. Carole B. Miller, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard F. Ambinder, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Emmanuel S. Antonarakis, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John J. Strouse, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Elizabeth M. Jaffee, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ronald B. Gartenhaus, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Edward A. Sausville, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Christopher G. Kanakry, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christine L. Hann, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Paul E. Gormley, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Fang Yin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mark J. Levis, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Yue Wang, MD |
|
|
Laxmi H. Iyer, MB BS |
|
|
Dr. Michael T. Schweizer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Yan Ji, MD |